Scroll Down

Immuno-Oncology Perspectives

Immuno-oncology (IO) is one of the most important developments to arise within oncology drug development. It has the potential to improve the lives of countless patients facing cancer today and in the near future. Q2 Solutions is an oncology development partner that understands the complexity of cancer research. 

We offer an end-to-end IO solution from discovery, to clinical development, to diagnostic testing and commercialization brought to you by our multi-disciplinary teams of scientific experts (i.e., AP/molecular, biomarker, CDx, IVD, genomics, and bioinformatics), global access to a wide range of tests and technologies, all backed by a logistics infrastructure, harmonized processes and quality systems that deliver smooth and efficient sample management processes that yield on-time high quality results you can trust. 

Explore how we can support your IO clinical development needs through multiple technologies and innovative new solutions to support this new era of immuno-oncology clinical development.

The Pivotal Roles Genomics and Flow Cytometry Play in Immuno-oncology Clinical Development
Insight Brief

The Pivotal Roles Genomics and Flow Cytometry Play in Immuno-oncology Clinical Development

Clinical Trials Laboratories in the Immuno-oncology Setting

View
Insight Brief

3 Tools You Should Be Using Now to Improve Oncology Care through Minimal Residual Disease Testing

Minimal Residual Disease: Finding the Right Test for the New Definition of Remission

View
White Paper

2 Essential Approaches You Should be Using Now for Minimal Residual Disease Detection in Oncology

Minimal Residual Disease Detection: Key Considerations for Clinical Development in Oncology

View
Infographic

Learn 3 Ways Anatomic Pathology Drives Advancements in Immuno-Oncology

Global Anatomic Pathology Solutions

View
Infographic

Learn 3 Ways to Optimize Your Companion Diagnostic Strategy

Companion Diagnostics Expertise

View
Insight Brief

4 Ways Central Laboratories Shape Immuno-oncology Drug Development

The Power of the Central Laboratory for Immuno-Oncology Drug Development

View
White Paper

Fighting Cancer: How Biomarker Testing and 3 Key Research Tools Shape Immunotherapy Drug Development

Planning and Implementing Biomarker Testing for Immuno-Oncology Trials

View